BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7230 related articles for article (PubMed ID: 2657539)

  • 1. Benign conjunctival melanocytic lesions. Clinicopathologic features.
    Folberg R; Jakobiec FA; Bernardino VB; Iwamoto T
    Ophthalmology; 1989 Apr; 96(4):436-61. PubMed ID: 2657539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ultrastructure of conjunctival melanocytic tumors.
    Jakobiec FA
    Trans Am Ophthalmol Soc; 1984; 82():599-752. PubMed ID: 6398936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva.
    Jakobiec FA; Folberg R; Iwamoto T
    Ophthalmology; 1989 Feb; 96(2):147-66. PubMed ID: 2649838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
    LeBlanc RE; Miller DM; Zegans ME
    J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile conjunctival nevus: clinicopathologic analysis of 33 cases.
    Thiagalingam S; Johnson MM; Colby KA; Zembowicz A
    Am J Surg Pathol; 2008 Mar; 32(3):399-406. PubMed ID: 18300811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
    Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
    Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnosis and management of melanocytic lesions of the ocular surface].
    Tóth G; Szalai E; Csákány B; Hécz R; Sándor GL; Lukáts O; Nagy ZZ; Szentmáry N
    Orv Hetil; 2020 Apr; 161(15):563-574. PubMed ID: 32320191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blue Nevi of the Ocular Surface: Clinical Characteristics, Pathologic Features, and Clinical Course.
    Sayed-Ahmed I; Murillo JC; Monsalve P; Ulloa JP; Fernandez MP; Wong J; Elgart G; Galor A; Dubovy SR; Karp CL
    Ophthalmology; 2018 Aug; 125(8):1189-1198. PubMed ID: 29551421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigmented conjunctival and scleral lesions.
    Liesegang TJ
    Mayo Clin Proc; 1994 Feb; 69(2):151-61. PubMed ID: 8309267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
    Sugiura M; Colby KA; Mihm MC; Zembowicz A
    Am J Surg Pathol; 2007 Feb; 31(2):185-92. PubMed ID: 17255762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual conjunctival melanocytic proliferations. Report of five cases and review of the literature.
    Eder A; Milman T; Mudhar HS; Lally SE; Shields CL; Bui K; Wells JR; Grossniklaus HE
    Surv Ophthalmol; 2024; 69(2):230-240. PubMed ID: 37890676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinicopathologic characteristics of 422 conjunctival melanocytic nevi specimens].
    Zhang ZB; Liang QF; Huang JJ; Li B
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):583-587. PubMed ID: 28851198
    [No Abstract]   [Full Text] [Related]  

  • 15. Pagetoid melanocytosis. Histologic features in benign and malignant lesions.
    Haupt HM; Stern JB
    Am J Surg Pathol; 1995 Jul; 19(7):792-7. PubMed ID: 7793477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nevi of conjunctiva as a risk factor of melanoma].
    Balaeva RN; Kasimov EM
    Vestn Oftalmol; 2016; 132(3):21-25. PubMed ID: 27456560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
    Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
    Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of melanocytic conjunctival tumors.
    Halas JM; Svetlosakova Z; Babal P
    Bratisl Lek Listy; 2013; 114(8):446-50. PubMed ID: 23944618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 362.